Nath Bio-Genes (India) Limited (NATHBIOGEN) — Cash Flow-to-Debt Ratio
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Cash Flow-to-Debt Ratio of -0.33x as of September 2025, meaning its operating cash flow of Rs-1.09 Billion could theoretically repay 0% of its total liabilities (Rs3.34 Billion) in one year. See Nath Bio-Genes (India) Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nath Bio-Genes (India) Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Nath Bio-Genes (India) Limited across 13 annual periods. Also explore NATHBIOGEN net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Nath Bio-Genes (India) Limited (2013–2025)
Year-by-year debt coverage analysis for Nath Bio-Genes (India) Limited. For market capitalisation and broader financial context, see Nath Bio-Genes (India) Limited (NATHBIOGEN) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | Rs175.81 Million | Rs3.82 Billion | ▼ -79.8% |
| 2024 | 0.23x | Rs614.80 Million | Rs2.70 Billion | ▲ +30.2% |
| 2023 | 0.17x | Rs383.67 Million | Rs2.20 Billion | ▲ +104.9% |
| 2022 | 0.09x | Rs170.46 Million | Rs2.00 Billion | ▲ +1250.1% |
| 2021 | 0.01x | Rs11.13 Million | Rs1.76 Billion | ▼ -88.5% |
| 2020 | 0.05x | Rs94.74 Million | Rs1.72 Billion | ▲ +134.6% |
| 2019 | -0.16x | Rs-219.89 Million | Rs1.38 Billion | ▲ +65.5% |
| 2018 | -0.46x | Rs-469.84 Million | Rs1.02 Billion | ▼ -2191.4% |
| 2017 | 0.02x | Rs33.43 Million | Rs1.52 Billion | ▲ +122.6% |
| 2016 | -0.10x | Rs-141.68 Million | Rs1.45 Billion | ▼ -271.7% |
| 2015 | 0.06x | Rs67.55 Million | Rs1.19 Billion | ▼ -59.1% |
| 2014 | 0.14x | Rs150.28 Million | Rs1.08 Billion | ▼ -1.4% |
| 2013 | 0.14x | Rs142.11 Million | Rs1.01 Billion | — |